论文部分内容阅读
介绍近2年来抗癌方剂实验研究的最新进展。介绍了涤痰化瘀汤、加味四逆泻心汤、四君子汤、仙鱼汤、健脾理气方、益气解毒方、抑肺饮、消积饮、胃宁颗粒、昆参颗粒、润肺散结胶囊、灵芪胶囊、反左金丸、肺一丸、星半通膈散、二鳖散、平瘤合剂、肺抑瘤合剂、连黛片、清毒栓等36个方剂对肿瘤相关基因p53、p16、p21、Rb、PTEN、c-myc、c-jun、c-erbB、Bcl-2、Bax、hTERT、VEGF、endostatin、cadherins、MMPs、COX-2、IGF-Ⅱ、bFGF、GFAP表达的影响。
The recent progress of experimental research on anticancer prescriptions in recent 2 years is introduced. Introduced Ditan phlegm and blood stasis soup, savory Sini Xiexin soup, Sijunzi soup, Angelfish soup, spleen Qi side, Qi and detoxification side, inhibition of lung drink, consumer product Yin, Wei Ning particles, Kun Shen particles, Sanjie Capsule, Anti-Zuojin Pill, Lung-Pill, Xingyutongwan San, Erbian San, Pingni Mixture, Lung Yiliu Mixture, Lian Dian Tablet and Qingdu Suppository, , P16, p21, Rb, PTEN, c-myc, c-jun, c-erbB, Bcl-2, Bax, hTERT, VEGF, endostatin, cadherins, MMPs, COX- 2, IGF- II, bFGF, GFAP influences.